Not applicableEnded earlyNCT01954576What this trial is testingNovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastomaBrain Neoplasms University of Florida 21
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Early research (Phase 1)Study completedNCT02323880What this trial is testingSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasWho this might be right forMalignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more Children's Oncology Group 59
Early research (Phase 1)Study completedNCT00063973What this trial is testingCilengitide in Treating Children With Refractory Primary Brain TumorsWho this might be right forChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00268359What this trial is testingBevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory GliomasWho this might be right forBrain and Central Nervous System Tumors Duke University 68
Testing effectiveness (Phase 2)Study completedNCT00004688What this trial is testingPhase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsWho this might be right forAnaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Gliomas+2 more Emory University 35
Testing effectiveness (Phase 2)Study completedNCT03243851What this trial is testingStudy on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory GlioblastomaWho this might be right forGlioblastoma Yong-Kil Hong 81
Large-scale testing (Phase 3)Ended earlyNCT00761280What this trial is testingEfficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary GlioblastomaWho this might be right forAnaplastic AstrocytomaGlioblastoma Isarna Therapeutics GmbH 27
Early research (Phase 1)Study completedNCT00138216What this trial is testingTemozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific Children's Oncology Group 42
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Early research (Phase 1)Study completedNCT00526812What this trial is testingA Safety Study of RTA 744 in Patients With Recurrent High-Grade GliomasWho this might be right forGlioma Biogen 54
Testing effectiveness (Phase 2)Study completedNCT03660761What this trial is testingApatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant TumorsWho this might be right forEfficacy and Safety Rongjie Tao 25
Testing effectiveness (Phase 2)Study completedNCT02684058What this trial is testingStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsWho this might be right forDiffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+19 more Novartis Pharmaceuticals 151
Early research (Phase 1)Study completedNCT01082926What this trial is testingPhase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2Who this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Meningioma+11 more City of Hope Medical Center 6
Early research (Phase 1)Study completedNCT01295632What this trial is testingSafety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)Who this might be right forAdvanced Cancer Merck Sharp & Dohme LLC 65
Early research (Phase 1)Ended earlyNCT00990496What this trial is testingA Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)Who this might be right forGlioblastoma Multiforme Milton S. Hershey Medical Center 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05540275What this trial is testingTislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Henan Provincial People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT01269853What this trial is testingRepeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AAWho this might be right forGlioblastoma MultiformeAnaplastic Astrocytoma Northwell Health 54
Early research (Phase 1)Study completedNCT00544284What this trial is testingBortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to TreatmentWho this might be right forBrain and Central Nervous System TumorsLymphomaMetastatic Cancer+1 more City of Hope Medical Center 25
Early research (Phase 1)Study completedNCT00946335What this trial is testingABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more National Cancer Institute (NCI) 31